Loading patent…
AssigneeBetz Laboratories, Inc.
InventorsDeborah K. Donofrio, Wilson K. Whitekettle
Estimating the term…
Bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose, of 2-bromo-2-nitropropane-1,3-diol (BNPD) and "Kathon 886F." The active biocidal components of the "Kathon 886F" product are: 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one. The method comprises administering between about 0.1 to about 200 parts of this composition (i.e., BNPD and "Kathon 886F" product) (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
A bacterial inhibiting composition comprising a synergistic, aqueous mixture of (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) a mixture of about 75% 5-chloro-2-methyl-4-isothiazolin-3-one and about 25% 2-methyl-4-isothiazolin-3-one, the weight ratio of said BNPD (a) to said mixture (b) being from about 16:1 to about 1:1.
A method for controlling the growth of Klebsiella pneumoniae bacteria in an aqueous system which comprises adding to said system from about 0.1 to about 200 parts per weight of a synergistic composition per one million parts per weight of said aqueous system, said composition comprising (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) a mixture of about 75% 5-chloro-2-methyl-4-isothiazolin-3-one and 25% 2-methyl-4-isothiazolin-3-one, wherein the weight ratio of said BNPD (a) to mixture (b) is from about 16:1 to about 1:1.
Dependencies are inferred from the claim text.